Merger Model: Accretion and Dilution Analysis Explained for Beginners

STATUS: Detailed Outline — Ready to Draft

Word target: 1,800–2,100 words Who this is for: Students targeting M&A advisory or corporate development roles; junior analysts whose team is working on a buy-side or sell-side mandate; anyone preparing for IB summer analyst or full-time technical interviews. Real-world question this post answers: “If AcquirerCo buys TargetCo for £12 per share in a deal financed 50% cash and 50% stock, will the combined company earn more or less per share than AcquirerCo does today? And does that change if the deal is financed all-cash instead?”

---

Learning Objectives

1. Define accretion and dilution in a merger context and explain why it matters
2. Understand the three financing methods and how each affects EPS
3. Build a simple merger model: standalone P&Ls → combined P&L → pro forma EPS
4. Calculate the accretion/dilution percentage and breakeven synergy level
5. Run a sensitivity analysis on offer price and synergy assumptions

---

Post Outline

Introduction (~200 words)

• Hook: after a merger is announced, the first headline is almost always about whether the deal is “accretive” or “dilutive” to earnings per share. It sounds technical, but the concept is simple: will the combined company earn more per share or fewer shares per share than the acquirer did on a standalone basis?
• The merger model is the key tool investment banks use to answer this question — and to advise the acquirer on what price it can pay while still delivering accretion.

Section 1: What Is Accretion/Dilution? (~200 words)

• Accretive deal: the combined company’s EPS is higher than the acquirer’s standalone EPS
• Dilutive deal: the combined company’s EPS is lower than the acquirer’s standalone EPS
• Why it matters: EPS accretion/dilution is a shorthand proxy for whether the deal creates value for the acquirer’s shareholders. Most boards and management teams are reluctant to pursue a dilutive deal without a compelling strategic rationale.
• The limitations: EPS accretion/dilution ignores cash flow, balance sheet, and strategic value. A deal can be EPS accretive and still destroy value (if it overpays or the target has lower returns than the acquirer’s WACC). Sophisticated analysts use accretion/dilution as a screen, not a verdict.

Section 2: The Three Financing Methods (~250 words)

All-cash deal:

• Acquirer uses cash on balance sheet or raises debt to pay the purchase price
• New shares are not issued → existing EPS denominator unchanged
• But: incremental interest expense on any new debt reduces net income
• Typically accretive if the target’s earnings yield (E/P) > after-tax interest rate on debt used

All-stock deal:

• Acquirer issues new shares to target shareholders at the agreed exchange ratio
• No cash leaves the business → no new interest expense
• But: new shares are issued → EPS denominator increases
• Accretive if target’s P/E < acquirer’s P/E (acquirer buys “cheap” earnings with “expensive” shares)

Mixed (cash + stock):

• Combination of the two: partial dilution from new shares + partial interest from debt
• Most real-world deals use a mix

Worked example: AcquirerCo (P/E = 18×, EPS = £0.50, shares = 10m) buys TargetCo (P/E = 12×) for £12 per share.

Section 3: Building the Merger Model (~400 words)

Step 1: Standalone P&Ls

• AcquirerCo: Revenue £50m, EBIT £7m, Net Income £5m, EPS £0.50
• TargetCo: Revenue £20m, EBIT £2.4m, Net Income £1.8m, EPS £0.36

Step 2: Transaction structure

• Offer price: £12/share
• TargetCo shares: 5m → purchase price = £60m
• Financing: 50% cash (£30m borrowed at 6%), 50% stock (£30m of AcquirerCo shares at current price £9)
• New AcquirerCo shares issued: £30m / £9 = 3.33m shares

Step 3: Purchase price adjustments

• Goodwill = Purchase Price − Fair Value of Net Assets
• Amortisation of acquired intangibles (D&A uplift): typically 5–15 years for customer relationships, technology, brand
• This creates an additional P&L charge in the combined company

Step 4: Synergies

• Revenue synergies: cross-selling opportunities, pricing improvements → harder to quantify, typically excluded from base case
• Cost synergies: overlapping overheads, procurement savings → more predictable, use as the base case
• Assume £500k of annualised cost synergies, phased in over 2 years (50% Year 1, 100% Year 2+)

Step 5: Pro forma combined P&L

Combined Revenue        = AcquirerCo Revenue + TargetCo Revenue (no rev synergies in base)
Combined EBIT           = Sum of EBITs − Intangible amortisation + Cost synergies
Combined Interest       = AcquirerCo interest + New debt interest
Combined Pre-tax Profit = Combined EBIT − Combined Interest
Combined Net Income     = Pre-tax × (1 − Tax Rate)
Pro Forma Shares        = AcquirerCo shares + New shares issued
Pro Forma EPS           = Combined Net Income / Pro Forma Shares

Step 6: Accretion/Dilution

Accretion/(Dilution) % = (Pro Forma EPS − Standalone EPS) / Standalone EPS × 100

In the worked example: Pro Forma EPS ≈ £0.52 → Accretion of ~4%

Section 4: The Breakeven Synergy Analysis (~200 words)

• What level of synergies is required to make the deal exactly EPS-neutral (0% accretion/dilution)?
• Build a sensitivity table: rows = synergies (£0k to £1,000k), columns = offer price per share (£10 to £14)
• Highlight in green all combinations that are accretive; red for dilutive
• This table is extremely common in IB pitch materials — it frames the synergy case the deal requires

Section 5: When EPS Analysis Is Not Enough (~200 words)

• Value creation vs EPS accretion: an all-cash deal funded by debt at 6% is accretive if TargetCo’s earnings yield > 6%. But if AcquirerCo’s WACC is 10%, it is destroying value even while reporting EPS accretion.
• Dilution does not mean the deal is bad: paying up for a genuinely transformational target can be strategically correct even if immediately dilutive
• What to look at alongside EPS: DCF of synergies, IRR of the transaction, ROIC vs WACC in years 3–5

Key Takeaways

• Accretive = combined EPS > standalone EPS; dilutive = combined EPS < standalone EPS
• All-cash deals: new interest expense is the EPS headwind; all-stock deals: share count increase is the headwind
• Lower P/E targets are more easily accretive in stock deals; higher earnings yield targets are more easily accretive in cash deals
• Always show the breakeven synergy table — it frames what the deal requires to work
• EPS accretion/dilution is a screen, not a verdict; complement with DCF and ROIC analysis

Practice Suggestion

Build the AcquirerCo/TargetCo merger model with both an all-cash and an all-stock scenario. Calculate accretion/dilution for each. Build the breakeven synergy table. Write one paragraph summarising which financing structure the M&A advisory team should recommend and why.

CTAs

• Inline: Download the merger model template
• End: Book a session to prep for your M&A IB technical interview

---

SEO & Internal Linking Notes

• Internal links: ← Precedent Transactions; ← LBO Model; ← Trading Comps
• Diagram: Combined P&L build (standalone + standalone → adjustments → pro forma)
• Table: Breakeven synergy table (accretion/dilution by offer price × synergy level)